Clinical Trial Update: Study of Different Doses of a Novel Treatment for Onychomycosis [Phase 2]

View source ↗

Summary

Phase 2 trial update on different doses of a novel treatment for distal subungual onychomycosis (nail fungus) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Distal Subungual Onychomycosis

Drugs mentioned

• Novel treatment (unspecified)

Snippet

Sponsor: Pfizer | Conditions: Distal, Subungual Onychomycosis | Phase 2 | Status: COMPLETED